4//SEC Filing
Radius Health, Inc. 4
Accession 0001104659-15-003029
CIK 0001428522operating
Filed
Jan 15, 7:00 PM ET
Accepted
Jan 16, 9:10 PM ET
Size
22.5 KB
Accession
0001104659-15-003029
Insider Transaction Report
Form 4
F2 Bioscience IV L.P.
10% Owner
Transactions
- Other
Common Stock Warrant
2015-01-16−121,396→ 0 total(indirect: By Fund)Exercise: $2.69From: 2014-02-14Exp: 2019-02-14→ Common Stock (121,396 underlying) - Other
Common Stock
2015-01-16−1,794,983→ 0 total - Other
Common Stock Warrant
2015-01-16−249,932→ 0 totalExercise: $2.69From: 2014-02-14Exp: 2019-02-14→ Common Stock (249,932 underlying) - Other
Common Stock
2015-01-16−871,851→ 0 total(indirect: By Fund)
F2 Bioscience IV GP Ltd.
10% Owner
Transactions
- Other
Common Stock
2015-01-16−1,794,983→ 0 total - Other
Common Stock Warrant
2015-01-16−121,396→ 0 total(indirect: By Fund)Exercise: $2.69From: 2014-02-14Exp: 2019-02-14→ Common Stock (121,396 underlying) - Other
Common Stock
2015-01-16−871,851→ 0 total(indirect: By Fund) - Other
Common Stock Warrant
2015-01-16−249,932→ 0 totalExercise: $2.69From: 2014-02-14Exp: 2019-02-14→ Common Stock (249,932 underlying)
F2 Capital Ltd
10% Owner
Transactions
- Other
Common Stock Warrant
2015-01-16−121,396→ 0 total(indirect: By Fund)Exercise: $2.69From: 2014-02-14Exp: 2019-02-14→ Common Stock (121,396 underlying) - Other
Common Stock Warrant
2015-01-16−249,932→ 0 totalExercise: $2.69From: 2014-02-14Exp: 2019-02-14→ Common Stock (249,932 underlying) - Other
Common Stock
2015-01-16−871,851→ 0 total(indirect: By Fund) - Other
Common Stock
2015-01-16−1,794,983→ 0 total
F2 Bio Ventures V L.P.
10% Owner
Transactions
- Other
Common Stock
2015-01-16−1,794,983→ 0 total - Other
Common Stock Warrant
2015-01-16−121,396→ 0 total(indirect: By Fund)Exercise: $2.69From: 2014-02-14Exp: 2019-02-14→ Common Stock (121,396 underlying) - Other
Common Stock Warrant
2015-01-16−249,932→ 0 totalExercise: $2.69From: 2014-02-14Exp: 2019-02-14→ Common Stock (249,932 underlying) - Other
Common Stock
2015-01-16−871,851→ 0 total(indirect: By Fund)
F2 Bio Ventures GP Ltd.
10% Owner
Transactions
- Other
Common Stock Warrant
2015-01-16−249,932→ 0 totalExercise: $2.69From: 2014-02-14Exp: 2019-02-14→ Common Stock (249,932 underlying) - Other
Common Stock
2015-01-16−1,794,983→ 0 total - Other
Common Stock
2015-01-16−871,851→ 0 total(indirect: By Fund) - Other
Common Stock Warrant
2015-01-16−121,396→ 0 total(indirect: By Fund)Exercise: $2.69From: 2014-02-14Exp: 2019-02-14→ Common Stock (121,396 underlying)
Globeways Holdings Ltd
10% Owner
Transactions
- Other
Common Stock
2015-01-16−871,851→ 0 total(indirect: By Fund) - Other
Common Stock Warrant
2015-01-16−121,396→ 0 total(indirect: By Fund)Exercise: $2.69From: 2014-02-14Exp: 2019-02-14→ Common Stock (121,396 underlying) - Other
Common Stock Warrant
2015-01-16−249,932→ 0 totalExercise: $2.69From: 2014-02-14Exp: 2019-02-14→ Common Stock (249,932 underlying) - Other
Common Stock
2015-01-16−1,794,983→ 0 total
Priestley Katherine
10% Owner
Transactions
- Other
Common Stock Warrant
2015-01-16−249,932→ 0 totalExercise: $2.69From: 2014-02-14Exp: 2019-02-14→ Common Stock (249,932 underlying) - Other
Common Stock
2015-01-16−1,794,983→ 0 total - Other
Common Stock
2015-01-16−871,851→ 0 total(indirect: By Fund) - Other
Common Stock Warrant
2015-01-16−121,396→ 0 total(indirect: By Fund)Exercise: $2.69From: 2014-02-14Exp: 2019-02-14→ Common Stock (121,396 underlying)
Footnotes (4)
- [F1]Reflects a liquidating pro rata distribution by F2 Bioscience IV L.P. ("F2 IV") to its limited and general partners.
- [F2]The reported securities are owned directly by F2 IV. F2 Bioscience IV GP Ltd. ("F2 IV GP") is the General Partner of F2 IV. Katherine Priestley and Globeways Holdings Limited ("Globeways") are members of F2 IV GP. F2 Capital Limited ("F2 Capital") is an investment adviser to F2 IV. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- [F3]Reflects a liquidating pro rata distribution by F2 Bio Ventures V L.P. ("F2 Bio") to its limited and general partners.
- [F4]The reported securities are owned directly by F2 Bio. F2 Bio Ventures GP Ltd. is the General Partner of F2 Bio. Globeways is the sole member of F2 Bio Ventures GP Ltd. F2 Capital is an investment adviser to F2 Bio. Each of the reporting persons disclaims beneficial ownership of the securities reported herein except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
Documents
Issuer
Radius Health, Inc.
CIK 0001428522
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001428522
Filing Metadata
- Form type
- 4
- Filed
- Jan 15, 7:00 PM ET
- Accepted
- Jan 16, 9:10 PM ET
- Size
- 22.5 KB